| Hugo J W L Aerts | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Spyridon Bakas | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Ronald Boellaard | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Ir??ne Buvat | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Christos Davatzikos | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Christos Davatzikos | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Mathieu Hatt | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Philippe Lambin | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Ralph T H Leijenaar | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Henning M??ller | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Arman Rahmim | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Esther G C Troost | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |
| Vincenzo Valentini | From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, S. Lock) National Center for Tumor Diseases (NCT), Germany: German Cancer Research Center (DKFZ), Germany (A.Z.) Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), and German Cancer Research Center (DKFZ), McGill University, Moffitt Cancer Center, Fla (M.A.A.) Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Mass (H.J.W.L.A.) Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, A.R.) Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Perelman School of Medicine, University of Groningen, University Medical Center Groningen (UMCG), VU University Medical Centre (VUMC), University Hospital Zurich, University of Zurich, S.T.L.) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Universite Paris Saclay, Inserm, Institut Curie, King's College London, Lausanne University Hospital, INSERM, the Netherlands Cancer Institute (NKI), Stanford University School of Medicine, University of Michigan, Brigham and Women's Hospital and Harvard Medical School, German Cancer Research Center (DKFZ), Maastricht University Medical Centre+, University of Tubingen, University of Bergen, University of California, Calif (O.M.) University of Geneva, Stanford University, University of British Columbia, Cardiff University, Velindre Cancer Centre, Institute of Radiooncology-OncoRay, Maastricht University Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Leiden University Medical Center (LUMC) |